Article Type
Changed
Mon, 03/04/2019 - 08:26
Display Headline
Dofetilide (Tikosyn): A new drug to control atrial fibrillation
Article PDF
Author and Disclosure Information

Walid I. Saliba, MD
Section of Cardiac Electrophysiology and Pacing, Department of Cardiology, Cleveland Clinic

Address: Walid I. Saliba, MD, Department of Cardiology, F15, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; salibaw@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 68(4)
Publications
Topics
Page Number
353-363
Sections
Author and Disclosure Information

Walid I. Saliba, MD
Section of Cardiac Electrophysiology and Pacing, Department of Cardiology, Cleveland Clinic

Address: Walid I. Saliba, MD, Department of Cardiology, F15, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; salibaw@ccf.org

Author and Disclosure Information

Walid I. Saliba, MD
Section of Cardiac Electrophysiology and Pacing, Department of Cardiology, Cleveland Clinic

Address: Walid I. Saliba, MD, Department of Cardiology, F15, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; salibaw@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Page Number
353-363
Page Number
353-363
Publications
Publications
Topics
Article Type
Display Headline
Dofetilide (Tikosyn): A new drug to control atrial fibrillation
Display Headline
Dofetilide (Tikosyn): A new drug to control atrial fibrillation
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media